Hallmark Capital Management Inc Pfizer Inc Transaction History

Hallmark Capital Management Inc

$1.32 Billion
Q3 2024

A detailed history of Hallmark Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Hallmark Capital Management Inc holds 678,742 shares of PFE stock, worth $18.1 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

678,742

Previous 649,809 4.45%

Holding current value

$18.1 Million

Previous $18.2 Million 8.04%

% of portfolio

1.48%

Previous 1.47%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $801,444 - $908,206	28,933 Added 4.45%	678,742 $19.6 Million
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $2.5 Million - $2.92 Million	98,802 Added 17.93%	649,809 $18.2 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $3.03 Million - $3.48 Million	117,205 Added 27.02%	551,007 $15.3 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $1.25 Million - $1.62 Million	-47,869 Reduced 9.94%	433,802 $12.5 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $304,181 - $355,557	9,479 Added 2.01%	481,671 $16 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $16,362 - $18,930	-453 Reduced 0.1%	472,192 $17.3 Million
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $644,853 - $839,504	16,371 Added 3.59%	472,645 $19.3 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $285,277 - $372,398	-6,833 Reduced 1.48%	456,274 $23.4 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $149,921 - $183,016	3,426 Added 0.75%	463,107 $20.3 Million
Q2 2022 Nov 16, 2022	SELL	$46.53 - $55.17 $159,411 - $189,012	-3,426 Reduced 0.74%	459,681 $24.1 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $773,886 - $917,587	-16,632 Reduced 3.49%	459,681 $24.1 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $201,711 - $249,946	-4,409 Reduced 0.92%	476,313 $24.7 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $1.01 Million - $1.49 Million	-24,403 Reduced 4.83%	480,722 $28.4 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $654,807 - $841,156	-16,683 Reduced 3.2%	505,125 $21.7 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $289,434 - $327,880	-8,060 Reduced 1.52%	521,808 $20.4 Million
Q1 2021 Apr 22, 2021	BUY	$33.49 - $37.77 $447,325 - $504,493	13,357 Added 2.59%	529,868 $19.2 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $329,411 - $418,875	-9,842 Reduced 1.87%	516,511 $19 Million
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $539,750 - $633,250	-17,000 Reduced 3.13%	526,353 $19.3 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $90,420 - $109,693	-3,002 Reduced 0.55%	543,353 $17.8 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $410,504 - $586,521	15,187 Added 2.86%	546,355 $17.8 Million
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $676,736 - $768,009	-20,557 Reduced 3.73%	531,168 $20.8 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $6.01 Million - $7.79 Million	184,828 Added 50.38%	551,725 $19.8 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $772,734 - $867,601	20,896 Added 6.04%	366,897 $15.9 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $1.25 Million - $1.37 Million	33,234 Added 10.63%	346,001 $14.7 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $3.79 Million - $4.32 Million	98,436 Added 45.93%	312,767 $13.7 Million
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $5.59 Million - $6.79 Million	162,295 Added 311.89%	214,331 $9.45 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $85,022 - $90,642	-2,578 Reduced 4.72%	52,036 $1.89 Million
Q1 2018 Apr 27, 2018	BUY	$31.91 - $37.02 $42,280 - $49,051	1,325 Added 2.49%	54,614 $1.94 Million
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $61,131 - $64,863	1,838 Added 3.57%	53,289 $1.93 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $1.59 Million - $1.76 Million	51,451	51,451 $1.84 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.

Account

Hallmark Capital Management Inc Pfizer Inc Transaction History